mitochondrial pyruvate carrier (MPC) inhibitor by Pelage in early trials
a novel topical treatment that inhibits DHT on androgen receptors
highly targeted anti-androgen that might have minimal systemic effects
plant and natural oil with antimicrobial and some anti-androgenic effects